Fujitsu Computer Systems
Fujitsu Transfers BioSciences Group to Provide Enhanced Service and Support to Life Sciences Market
Fujitsu Computer Systems Corporation, a wholly-owned subsidiary of Fujitsu Limited, announced the transfer of the BioSciences Group, a worldwide leader in providing innovative and reliable solutions to experimental scientists, from Fujitsu America, Inc. to Fujitsu Computer Systems Corporation.
Sunnyvale, CA, April 14, 2005 — "We are very pleased to have The BioSciences Group join Fujitsu Computer Systems," said Toshio Morohoshi, President & CEO, Fujitsu Computer Systems Corporation. "We see this transfer as the ideal integration of expertise and services. The BioSciences Group gains expertise in enterprise-scale solutions, and provides life sciences-specific technologies and services in order to introduce Fujitsu offerings in the North American life sciences market."
Takahiro Tsunekawa, Vice President of The BioIT Solutions Group said, "The transfer of the BioSciences Group to Fujitsu Computer Systems will result in even stronger responsiveness and service for our customers in North America who will benefit from improved integration of support and logistics."
The BioSciences Group offerings for drug discovery range from hardware to software and services designed to enable researchers to make in silico predictions about leads, targets and interactions – and to validate these hypotheses experimentally. The BioSciences Group's products and services include the BioServer™, a massively parallel server designed specifically for life sciences applications, which complements the existing Fujitsu portfolio of products and services, including the recently-announced PRIMEQUEST™ server line. The BioSciences Group also brings the award-winning CAChe® and BioMedCAChe™ desktop molecular modeling software suites, and the "Large-scale in situ Hybridization" (LisH™) service for creating massive gene expression image databases.
About The BioSciences Group of Fujitsu Computer Systems
The BioSciences Group, a division of Fujitsu Computer Systems Corporation, capitalizes on Fujitsu Limited's over 20 years
of leadership in creating innovative and reliable solutions for helping experimental scientists overcome the challenges in
their laboratory workflow. BioSciences Group solutions provide a framework for researchers to make in silico predictions about
leads, targets, and interactions, and to validate these hypotheses experimentally.
BioSciences Group offerings include the CAChe® suite of life sciences predictive modeling tools, the ActiveSite™
module for drug discovery lead-generation, and the BioServer™ massively parallel simulation server for genomics-based
drug design. For more information, please see: us.fujitsu.com/biosciences.
About Fujitsu Computer Systems
Headquartered in Sunnyvale, Calif., Fujitsu Computer Systems is a wholly owned subsidiary of Fujitsu Limited (TSE:6702) committed to the design, development and delivery of advanced computer systems and managed services for the business enterprise. The company offers a complete line of high-performance mobile computers, scalable and reliable servers, storage, and middleware as well as managed and professional services. Fujitsu Computer Systems emphasizes leading-edge technology, exceptional product quality and user comfort and productivity, as well as outstanding customer service. More information on Fujitsu Computer Systems is available at: us.fujitsu.com/computers.
About Fujitsu
Fujitsu is a leading provider of customer-focused IT and communications solutions for the global marketplace. Pace-setting technologies, highly reliable computing and communications platforms, and a worldwide corps of systems and services experts uniquely position Fujitsu to deliver comprehensive solutions that open up infinite possibilities for its customers' success. Headquartered in Tokyo, Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.7 trillion yen (US$45 billion) for the fiscal year ended March 31, 2004. For more information, please see: www.fujitsu.com.
Fujitsu, the Fujitsu logo, BioServer, BioMedCAChe, CAChe, and PRIMEQUEST are registered trademarks or trademarks of Fujitsu Limited in the United States and other countries. LisH is a trademark of Celestar-Lexico Sciences in the United States and other countries. All other trademarks and product names are the property of their respective owners.
The statements provided herein are for informational purposes only and may be amended or altered by Fujitsu Computer Systems Corporation without notice or liability. Product description data represents Fujitsu design objectives and is provided for comparative purposes; actual results may vary based on a variety of factors. Specifications are subject to change without notice.
